ROTEM Interpretation AI vs Experts
ROTEMAI
Artificial Intelligence Versus Expert Interpretation of ROTEM: A Prospective Study of Agreement and Clinical Decision-Making
1 other identifier
observational
400
0 countries
N/A
Brief Summary
This prospective multicenter observational study aims to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings in clinically relevant settings. ROTEM is widely used to guide hemostatic therapy in perioperative and critically ill patients, but its interpretation is complex and subject to interobserver variability. The primary objective is to determine whether AI-based interpretation achieves agreement comparable to variability between expert clinicians. Secondary objectives include comparison of interpretation time, assessment of consistency of AI outputs, and evaluation of potential differences in clinical decision-making. ROTEM datasets will be independently assessed by multiple expert anesthesiologists and by an AI-based model using standardized input. Agreement between methods and variability of interpretation will be analyzed. The study aims to determine whether AI-assisted interpretation could serve as a reliable decision-support tool and reduce variability in ROTEM-guided clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 31, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 1, 2027
March 31, 2026
March 1, 2026
9 months
March 25, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement between AI-based and expert interpretation of ROTEM findings
Agreement between artificial intelligence (AI)-based interpretation and expert interpretation of ROTEM findings will be assessed and compared to inter-expert agreement. Agreement will be evaluated for predefined clinical decision outputs, including: * presence of coagulation disorder (yes/no), * identification of dominant coagulation abnormality (categorical), * selection of therapeutic intervention (categorical), * and recommended treatment dose (continuous). Agreement will be quantified using appropriate statistical methods for categorical and continuous data (e.g., Cohen's/Fleiss' kappa and intraclass correlation coefficients).
Up to 24 hours after ROTEM measurement (time required for interpretation and data recording).
Secondary Outcomes (4)
Interpretation time
Up to 24 hours after ROTEM measurement.
Consistency of interpretation (intra-method variability)
Up to 24 hours after ROTEM measurement
Proportion of clinically discordant decisions
Up to 24 hours after ROTEM measurement
Inter-expert agreement
Up to 24 hours after ROTEM measurement
Other Outcomes (1)
Potential treatment change
Up to 24 hours after ROTEM measurement
Study Arms (1)
Patients indicated for thromboelastography.
Intensive care unit adult patients that are indicated for thromboelastography.
Interventions
The thromboelastography record will be assessed by LLM based artificial intelligence.
Eligibility Criteria
The study population will consist of adult patients undergoing rotational thromboelastometry (ROTEM) as part of routine clinical care in participating centers. Patients will be recruited from perioperative and intensive care settings, including major surgery, trauma, and critical illness, where assessment of coagulation status is clinically indicated. This study reflects real-world practice, with no modification of standard care. The unit of analysis will be individual ROTEM measurements rather than individual patients, as repeated measurements may occur during clinical management. Only ROTEM datasets with complete graphical and numerical outputs and meeting predefined quality criteria will be included.
You may qualify if:
- Adult patients (age ≥18 years)
- ROTEM analysis performed using a ROTEM Sigma device as part of routine clinical care
- Availability of complete ROTEM output (graphical and numerical data)
- ROTEM measurement obtained in a clinical context where assessment of coagulation status is indicated (e.g., perioperative setting, trauma, or critical illness)
You may not qualify if:
- ROTEM measurements performed using the HEPTEM channel
- Incomplete or missing ROTEM data preventing standardized evaluation
- ROTEM measurements obtained under non-standardized or technically unreliable conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- deputy for science and research
Study Record Dates
First Submitted
March 25, 2026
First Posted
March 31, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
March 31, 2026
Record last verified: 2026-03